BALTIMORE--(BUSINESS WIRE)--Sept. 18, 2006--Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company, announced today that it will be added to the broad-market Russell 3000 Index. The Russell 3000 Index measures the performance of the 3,000 largest U.S. companies based on total market capitalization.
